According to ANCA Vasculitis News, the FDA recently approved Riabni (rituximab-arrx) for the treatment of adult patients with two specific subtypes of ANCA vasculitis: microscopic
In early January 2021, biopharmaceutical company BlueRock Therapeutics (“BlueRock”), in collaboration with the Memorial Sloan Kettering Cancer Center, announced via press release that its Investigational
According to a story from Globe Newswire, the genetic medicine company Sarepta Therapeutics has announced top-line data from part one of its clinical trial. This
When you think of malaria, are mosquitos the first image that appears? While a microscopic parasite, Plasmodium falciparum, is responsible for malaria, mosquitos are often
The statistics are grim. A survey of 12,000 US nursing homes finds over 56,000 COVID related deaths as of July 2020. This number represents ten
Veer Basal, age 14, first started showing signs of Friedreich’s ataxia when he was around ten years old. The first sign that something was wrong
© Copyright Patient Worthy
